BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22436624)

  • 21. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
    Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
    Rutgers JL; Bell DA
    Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
    Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
    Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonality of composite large cell neuroendocrine carcinoma and mucinous epithelial tumor of the ovary: a case study.
    Yasuoka H; Tsujimoto M; Fujita S; Kunishige I; Nishio Y; Kodama R; Oishi H; Sanke T; Nakamura Y
    Int J Gynecol Pathol; 2009 Jan; 28(1):55-8. PubMed ID: 19047907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms.
    McCluggage WG
    J Clin Pathol; 2012 Jul; 65(7):596-600. PubMed ID: 21768188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
    Chui MH; Ellenson LH
    Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive.
    Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM
    Int J Gynecol Pathol; 2006 Jan; 25(1):83-9. PubMed ID: 16306790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type.
    D'Angelo E; Dadmanesh F; Pecorelli S; Prat J
    Int J Gynecol Pathol; 2010 Nov; 29(6):529-32. PubMed ID: 20881861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
    Silva EG; Young RH
    Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
    Miller K; Millar J; McCluggage WG
    Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
    Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic subtypes of ovarian carcinoma: an overview.
    Soslow RA
    Int J Gynecol Pathol; 2008 Apr; 27(2):161-74. PubMed ID: 18317227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
    Kato N; Toukairin M; Asanuma I; Motoyama T
    Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.